ArticleClinical rheumatology2024

Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer.

Maria E Suarez-Almazor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.